Home > Official notices > Amendment to the Byelaws: Registration of overseas pharmacists  |  Search

The Pharmaceutical Journal
Vol 274 No 7346 p505
23 April 2005


Amendment to the Byelaws: Registration of overseas pharmacists

Notice is hereby given in accordance with Section XXVIII of the Byelaws that the Council of the Society, under its powers in the Pharmacy Act 1954, has approved proposals to alter the Byelaws on registration of overseas pharmacists (Section XIX) as hereunder and that it intends to make such alterations after the expiry of 60 days from the date of this notice, subject to such amendments as the Lords of the Privy Council may require.

Section XIX

Paragraph 3 — Delete paragraph and replace with:

3. Any person wishing to apply for registration pursuant to an agreement between the Society, in the exercise of powers conferred on the Council of the Society under any previous byelaws, and the authorities responsible for the registration of pharmacists —
(a) in South Africa; or
(b) in Australia; or
(c) in New Zealand, shall apply to the Registrar no later than noon on Friday 30 June 2006, in accordance with the provisions of paragraph 4.”

Paragraph 4 — Delete “A person making application for registration pursuant to an agreement entered into in accordance with the provisions of the preceding byelaw shall” and insert “A person making an application referred to in paragraph 3 shall”.

Ann Lewis
Secretary and Registrar

Note. The effect of the Byelaw amendment is to enable the Society to end its reciprocal registration agreements with the registration authorities in South Africa, Australia and New Zealand but retain the reciprocal registration agreement with Northern Ireland, the automatic registration of European Economic Area nationals with appropriate European diplomas as provided by the Pharmacy Act 1954 (as amended) and the Adjudicating Committee route for all other applicants who “hold a pharmaceutical qualification or qualifications comparable to an approved degree in pharmacy awarded in the UK but granted by a university, or a body of comparable academic status, outside the UK”.


News item, p495

Back to Top


©The Pharmaceutical Journal